Also trades as: 4528.T (JPX) · $vol 23M · OPHLF (OTC) · $vol 0M

$4.80

-0.04 (-0.85%)

Weekly Expected Move ±5.2%

$4 $5 $5 $5 $5

OTC · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 46 · $6.8B mcap · 389M float · 0.012% daily turnover · Short 42% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$546.9B +12.3% ▲

5Y CAGR: +12.1%

Gross Profit

$396.6B +17.0% ▲

5Y CAGR: +12.1%

Operating Income

$109.6B +83.4% ▲

5Y CAGR: +2.2%

Net Income

$74.0B +47.8% ▲

5Y CAGR: -0.4%

EPS (Diluted)

$52.73 +48.7% ▲

5Y CAGR: +0.9%

EBITDA

$149.6B +63.4% ▲

5Y CAGR: +5.1%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$361.4B	$447.2B	$502.7B	$486.9B	$546.9B
YoY Growth	+16.8%	+23.8%	+12.4%	-3.1%	+12.3%
Cost of Revenue	$93.5B	$110.1B	$127.1B	$147.9B	$150.3B
Gross Profit	$267.9B	$337.1B	$375.5B	$338.9B	$396.6B
Gross Margin	74.1%	75.4%	74.7%	69.6%	72.5%
R&D Expenses	$75.9B	$95.3B	$112.4B	$149.9B	$155.9B
SG&A Expenses	$74.1B	$86.6B	$97.4B	$122.2B	$131.2B
Operating Expenses	$164.7B	$195.2B	$212.4B	$279.2B	$287.1B
Operating Income	$103.2B	$142.0B	$163.1B	$59.7B	$109.6B
Operating Margin	28.6%	31.7%	32.4%	12.3%	20.0%
Interest Expense	$874M	$913M	$229M	$5.3B	$3.8B
Income Before Tax	$105.0B	$143.5B	$163.7B	$59.3B	$98.2B
Tax Expense	$24.3B	$30.6B	$35.7B	$9.2B	$24.1B
Net Income	$80.5B	$112.7B	$128.0B	$50.0B	$74.0B
Net Margin	22.3%	25.2%	25.5%	10.3%	13.5%
EPS (Diluted)	$54.05	$76.92	$88.87	$35.47	$52.73
EBITDA	$123.6B	$161.9B	$178.4B	$91.5B	$149.6B
Shares Outstanding	4.47B	4.40B	1.44B	1.41B	1.41B

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$117.7B	$122.7B	$134.2B	$112.3B	$127.5B	$131.9B	$142.4B	$120.9B
Cost of Revenue	$29.7B	$27.2B	$45.8B	$45.2B	$37.0B	$35.6B	$37.3B	$33.7B
Gross Profit	$88.0B	$95.5B	$88.4B	$67.1B	$90.5B	$96.3B	$105.1B	$87.3B
Gross Margin	74.8%	77.8%	65.9%	59.7%	71.0%	73.0%	73.8%	72.2%
R&D Expenses	$28.9B	$39.9B	$38.3B	$42.8B	$36.3B	$35.4B	$34.1B	$43.3B
SG&A Expenses	$27.9B	$30.5B	$35.3B	$31.9B	$31.1B	$30.6B	$32.3B	$31.4B
Operating Expenses	$57.3B	$69.9B	$73.5B	$78.1B	$68.5B	$66.0B	$66.4B	$74.6B
Operating Income	$30.7B	$25.5B	$14.9B	-$11.0B	$22.0B	$30.3B	$38.6B	$12.6B
Operating Margin	26.1%	20.8%	11.1%	-9.8%	17.2%	23.0%	27.1%	10.5%
Interest Expense	$75M	$3.9B	$0	$1.8B	$5M	$1.2B	$415M	$1.2B
Income Before Tax	$33.3B	$21.3B	$17.4B	-$12.7B	$22.6B	$30.0B	$37.9B	$3.3B
Tax Expense	$8.5B	$4.5B	$2.5B	-$6.3B	$5.0B	$7.3B	$8.5B	$2.3B
Net Income	$24.8B	$16.8B	$15.0B	-$6.5B	$17.7B	$22.9B	$29.4B	$833M
Net Margin	21.1%	13.7%	11.1%	-5.8%	13.9%	17.4%	20.6%	0.7%
EPS (Diluted)	$17.58	$11.94	$10.60	$-4.66	$12.53	$16.00	$20.85	$0.58
EBITDA	$35.1B	$29.8B	$24.0B	-$5.8B	$31.2B	$40.8B	$48.1B	$22.4B
Shares Outstanding	1.41B	1.41B	1.41B	1.41B	1.41B	1.41B	1.41B	1.45B

OPHLY OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet